Becker's Healthcare January 16, 2025
Alexandra Murphy

An analysis of the Inflation Reduction Act of 2022 found that a majority of Medicare Part D enrollees will see lower total out-of-pocket costs in 2025.

The law’s new $2,000 out-of-pocket spending cap for prescription drugs is expected to save most affected enrollees an average of $2,474, representing a 48% reduction in their overall spending, including premiums and cost sharing, according to the report published by AARP.

The analysis, which incorporates...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Insurance, Medicare, Patient / Consumer, Pharma, Pharma / Biotech, Survey / Study, Trends
Value-based payment models: Doctors describe the disconnect between theory and practice
Nurse anesthetists outnumber anesthesiologists billing Medicare
OIG report finds just 40% of Medicare enrollees who started treatment for opioid use disorder continued
Fewer psychiatrists are billing Medicare: 5 things to know
Psychiatrists participating in Medicare Part B declines: Study

Share This Article